[摘要] 目的 觀察分析BiPAP无创通气治疗II型呼吸衰竭并肺性脑病临床效果。 方法 随机选取该院2014年1月—2018年6月收治的II型呼吸衰竭并肺性脑病患者60例作为研究对象，按照治疗方法分为两组，每组30例，分别采用给予持续低流量吸氧(A组)及呼吸兴奋剂治疗和BiPAP无创通气(B组)治疗，对比两组的效果。结果 B组的治疗总有效率为86.67%，明显高于A组的56.67%(χ2=10.601，P0.05)。 结论 BiPAP无创通气治疗II型呼吸衰竭并肺性脑病，能够有效改善临床症状，促进气体交换和脑组织功能恢复，具有显著的临床应用效果。

 [关键词] BiPAP无创通气;II型呼吸衰竭;肺性脑病

 [中图分类号] R5 [文献标识码] A [文章编号] 1674-0742(2019)02(a)-0066-04

 [Abstract] Objective To observe the clinical effect of BiPAP non-invasive ventilation in the treatment of type II respiratory failure with pulmonary encephalopathy. Methods A total of 60 patients with type II respiratory failure and pulmonary encephalopathy admitted to our hospital from January 2014 to June 2018 were enrolled. The patients were divided into two groups according to the treatment method. Each group had 30 cases， respectively. Flow oxygen inhalation (group A) and respiratory stimulant therapy and BiPAP noninvasive ventilation (group B) were compared， and the effects of the two groups were compared. Results The total effective rate of treatment in group B was 86.67%， which was significantly higher than that in group A 56.67% (x2=10.601， P0.05). Conclusion BiPAP non-invasive ventilation for type II respiratory failure and pulmonary encephalopathy can effectively improve clinical symptoms， promote gas exchange and recovery of brain tissue function， and has significant clinical application effects., http://www.100md.com(蓝艳春) 第 1 2 页 下一页
 百拇医药网 http://www.100md.com/html/paper/1674-0742/2019/04/22.htm